- Filed
- Jul 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 31, 2025 | 804.07M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 807.8M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 804.1M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 785.6M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 783.2M sh |
| Dividends Paid | Q2 2025 · Jun 30, 2025 | $557.4M |
| Dividends Paid | Q2 2025 · Jun 30, 2025 | $1.11B |
| Dividends Paid | Q2 2025 · Jun 30, 2024 | $618.5M |
| Capex | Q2 2025 · Jun 30, 2025 | $235.7M |
| Capex | Q2 2025 · Jun 30, 2025 | $553.5M |
| Capex | Q2 2025 · Jun 30, 2024 | $331.8M |
| Capex | Q2 2025 · Jun 30, 2024 | $545.6M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $976.8M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $1.7B |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $962.1M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $1.62B |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $6.75B |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $5.76B |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $675.4M |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $245.3M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $3.33B |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $3.26B |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $9.98B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $9.17B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $1.33B |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $2.25B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $7B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $6.17B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $19.55B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $18.71B |
| Total Assets | Q2 2025 · Jun 30, 2024 | $17.78B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $1.21 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $2.39 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | $1.21 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | $2.15 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $1.21 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $2.39 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | $1.21 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | $2.15 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $32.5M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $64.1M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $33.9M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $64.8M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $1.59B |
| Operating Income | Q2 2025 · Jun 30, 2025 | $3.12B |
| Operating Income | Q2 2025 · Jun 30, 2024 | $1.61B |
| Operating Income | Q2 2025 · Jun 30, 2024 | $2.8B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $1.21B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $2.53B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $1.25B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $2.41B |
| Revenue | Q2 2025 · Jun 30, 2025 | $3.05B |
| Revenue | Q2 2025 · Jun 30, 2025 | $6.17B |
| Revenue | Q2 2025 · Jun 30, 2024 | $3.12B |
| Revenue | Q2 2025 · Jun 30, 2024 | $5.72B |